BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, Zeng Q, Xu M, Tang QZ. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways. Acta Pharmacol Sin 2021. [PMID: 34916609 DOI: 10.1038/s41401-021-00820-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng M, Fu Y, Wu C, Zhang Y, Ren H, Zhou S. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. Front Endocrinol 2022;13:907757. [DOI: 10.3389/fendo.2022.907757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tang K, Zhong B, Luo Q, Liu Q, Chen X, Cao D, Li X, Yang S. Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ye S, Wang B, Zhou Y, Sun Q, Yang X. Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling. Hum Exp Toxicol 2022;41:096032712211401. [DOI: 10.1177/09603271221140111] [Reference Citation Analysis]